Pradžia › Širdies nepakankamumas › Vermont
Širdies nepakankamumas klinikiniai tyrimai Vermont
8 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Vermont.
Miestai Vermont
Oficialus tyrimo tekstas (anglų kalba)
ELEVATE-HFpEF Clinical Study
- The University of Vermont Medical Center, Burlington
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06678841Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Burlington
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Burlington, VT Investigative Site 10053, Burlington
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06008197Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Burlington
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-20 · NCT00271180A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10053, Burlington, VT, Burlington
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Vermont, Burlington
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT05934487His-Bundle Corrective Pacing in Heart Failure
- University of Vermont, Burlington
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-09 · NCT05265520Left vs Left Randomized Clinical Trial
- University of Vermont, Burlington
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-02 · NCT05650658Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.